Citigroup Doubles Rivian Stake to New Record in Q3 2025
Citigroup doubled its Rivian stake to 8.54M shares ($125M value) in Q3 2025, reaching a four-year record.
Already have an account? Sign in.
Citigroup doubled its Rivian stake to 8.54M shares ($125M value) in Q3 2025, reaching a four-year record.
Microsoft sees Azure growth of 45%, topping estimates and delivering the largest one-day market-value gain ever recorded.
FDA panel votes 10-3 for Replimune’s RP1 melanoma drug after two rejections, citing benefits for resistant patients despite messy data.
Rivian reports stronger Q2 2026: $1.66B revenue, narrower losses. R2 debut and software segment fuel growth; full-year deliveries raised.